Table 5. Significance of SNPs in CUGBP2 in prediction of disease risk.
CCall APOE ε4/ε4 stratum | Caribbean Hispanic+WU+ADNI | CCun+Hispanic+WU+ADNI | |||||||||
SNP | Allelea | Nb | Pc | Nb | ORd | 95% CI | Pe | Nb | ORd | 95% CI | Pe |
rs11256915 | A | 408 | 0.286 | 1435 | 1.25 | 0.95–1.68 | 0.125 | 2382 | 1.43 | 1.13–1.83 | 3.3×10−3 |
rs2146551 | A | 407 | 0.055 | 1447 | 1.16 | 0.86–1.56 | 0.331 | 2393 | 1.35 | 1.05–1.73 | 0.018 |
rs731229 | G | 408 | 0.140 | 1444 | 1.16 | 0.83–1.62 | 0.378 | 2390 | 1.22 | 0.93–1.60 | 0.142 |
rs992193 | A | 408 | 0.313 | 1446 | 1.12 | 0.84–1.52 | 0.439 | 2391 | 1.20 | 0.95–1.53 | 0.118 |
rs2146553 | G | 408 | 0.033 | 1445 | 0.83 | 0.60–1.15 | 0.259 | 2392 | 0.81 | 0.63–1.05 | 0.106 |
rs10795839 | G | 408 | 0.488 | 1435 | 0.86 | 0.3–1.18 | 0.361 | 2382 | 0.86 | 0.66–1.14 | 0.305 |
rs1928724 | A | 407 | 0.698 | 1447 | 0.93 | 0.69–1.26 | 0.646 | 2394 | 0.94 | 0.72–1.23 | 0.655 |
rs1928722 | A | 408 | 0.789 | 1434 | 0.89 | 0.65–1.23 | 0.493 | 2381 | 0.88 | 0.66–1.16 | 0.371 |
rs201070 | A | 408 | 0.201 | 1446 | 0.96 | 0.71–1.29 | 0.793 | 2392 | 1.11 | 0.87–1.41 | 0.406 |
rs201071 | A | 407 | 0.018 | 1447 | 1.19 | 0.79–1.81 | 0.403 | 2394 | 1.49 | 1.06–2.11 | 0.022 |
rs201074 | A | 408 | 4.5×10−3 | 1433 | 0.69 | 0.48–1.00 | 0.052 | 2380 | 0.68 | 0.52–0.91 | 7.9×10−3 |
rs62209 | C | 402 | 3.8×10−3 | 1439 | 1.75 | 1.27–2.41 | 5.6×10−4 | 2371 | 2.04 | 1.56–2.67 | 1.6×10−7 |
rs201082 | G | 408 | 0.096 | 1435 | 1.61 | 1.14–2.29 | 7.5×10−3 | 2382 | 1.79 | 1.35–2.38 | 5.1×10−5 |
rs201097 | A | 408 | 0.509 | 1447 | 0.83 | 0.43–1.58 | 0.561 | 2394 | 0.75 | 0.46–1.22 | 0.248 |
rs201099 | A | 408 | 8.3×10−8 | 1447 | 1.56 | 1.12–2.18 | 9.1×10−3 | 2393 | 1.92 | 1.47–2.56 | 3.4×10−6 |
rs201100 | G | 408 | 0.019 | 1433 | 0.65 | 0.45–0.95 | 0.024 | 2380 | 0.68 | 0.52–0.89 | 4.9×10−3 |
rs201119 | A | 408 | 1.5×10−8 | 1447 | 1.43 | 1.00–2.03 | 0.048 | 2394 | 2.08 | 1.53–2.79 | 2.1×10−6 |
rs201124 | A | 408 | 1.3×10−6 | 1423 | 1.43 | 1.00–2.06 | 0.048 | 2370 | 1.82 | 1.34–2.46 | 1.2×10−4 |
rs7099713 | A | 408 | 2.3×10−4 | 1435 | 1.16 | 0.65–2.06 | 0.618 | 2381 | 1.45 | 0.94–2.22 | 0.096 |
rs1547221 | G | 408 | 4.4×10−5 | 1447 | 1.43 | 0.88–2.31 | 0.153 | 2394 | 1.82 | 1.24–2.64 | 1.9×10−3 |
rs913918 | A | 408 | 0.565 | 1434 | 1.47 | 1.04–2.09 | 0.029 | 2380 | 1.47 | 1.11–1.98 | 7.8×10−3 |
rs11256951 | G | 408 | 0.154 | 1435 | 0.95 | 0.70–1.28 | 0.740 | 2382 | 1.06 | 0.84–1.36 | 0.604 |
rs1999207 | A | 408 | 0.914 | 1447 | 0.92 | 0.67–1.24 | 0.568 | 2394 | 0.88 | 0.69–1.15 | 0.361 |
rs932918 | A | 407 | 0.908 | 1447 | 1.22 | 0.85–1.74 | 0.279 | 2392 | 1.12 | 0.84–1.50 | 0.420 |
Allele depicted is the allele with higher frequency in the APOE ε4/ε4 cases than ε4/ε4 controls, as denoted on the Illumina TOP strand.
Sample size.
P-value for relationship-corrected chi-square test of allele frequency differences.
Interaction odds ratio with respect to allele noted based on logistic regression model.
P-value for interaction coefficient of logistic model.